FDA clears Cerapedics' i-Factor bone graft for cervical fusion

The FDA has approved a biologic bone graft for use in the cervical spine. The i-Factor peptide-enhanced bone graft from Cerapedics Inc., a private orthobiologics company, got the nod as a drug-device combination product for use in ACDF procedures in patients with degenerative cervical disc disease.